<!-- received="Wed Dec 30 18:44:22 1998 MST" -->
<!-- sent="Wed, 30 Dec 1998 19:22:18 -0600" -->
<!-- name="Eliezer S. Yudkowsky" -->
<!-- email="sentience@pobox.com" -->
<!-- subject="Transplant Regenerating Neurons" -->
<!-- id="368AD1BF.71C6AA34@pobox.com" -->
<!-- inreplyto="" -->
<!-- version=1.10, linesinbody=87 -->
<html><head><title>extropy: Transplant Regenerating Neurons</title>
<meta name=author content="Eliezer S. Yudkowsky">
<link rel=author rev=made href="mailto:sentience@pobox.com" title ="Eliezer S. Yudkowsky">
</head><body>
<h1>Transplant Regenerating Neurons</h1>
Eliezer S. Yudkowsky (<i>sentience@pobox.com</i>)<br>
<i>Wed, 30 Dec 1998 19:22:18 -0600</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#3688">[ date ]</a><a href="index.html#3688">[ thread ]</a><a href="subject.html#3688">[ subject ]</a><a href="author.html#3688">[ author ]</a>
<!-- next="start" -->
<li><a href="3689.html">[ Next ]</a><a href="3687.html">[ Previous ]</a>
<b>In reply to:</b> <a href="0779.html">Brian D Williams</a>
<!-- nextthread="start" -->
</ul>
<!-- body="start" -->

<p>
<a href="http://www.eurekalert.org/releases/csmc-hbcts.html">http://www.eurekalert.org/releases/csmc-hbcts.html</a>

<p>
Apparently, now that they've gotten neurons (original adult, not fetal)
to regenerate in the test tube, the new idea is to put them back in,
thus curing Parkinson's and the like.  A considerably more complex
procedure is envisioned for treating spinal cord injuries and epilepsy.

<p>
I wonder:


<OL>
  <li>  Will these neurons keep regenerating forever, preventing senility?
  <li>  Why hasn't that occurred as a natural mutation?
  <li>  Could this transform non-infants into Algernons?


</OL>
<p>
<a href="0779.html#3688qlink1">&gt;       Human Brain Cell Transplantation Study</a><br>
<i>&gt;       Aims To Reverse Nerve And Brain</i><br>
<i>&gt;       Damage </i><br>
<i>&gt; </i><br>
<i>&gt;       LOS ANGELES (December 29, 1998) -- While growing cells in</i><br>
<i>&gt;       petri dishes has been done for more than a century, this old</i><br>
<i>&gt;       technique is being applied in ground-breaking new ways, and</i><br>
<i>&gt;       with space-age equipment, at Cedars-Sinai Medical Center's</i><br>
<i>&gt;       Neurofunctional Surgery Center. The goal is to produce cures for</i><br>
<i>&gt;       such previously incurable conditions as spinal cord injuries,</i><br>
<i>&gt;       stroke, epilepsy, and Parkinson's disease. Using molecular</i><br>
<i>&gt;       biology technology, scientists have developed specialized</i><br>
<i>&gt;       neuronal cells ready to be transplanted for certain neurological</i><br>
<i>&gt;       conditions. </i><br>
<i>&gt; </i><br>
<i>&gt;       The project was sparked by the recent discovery of human brain</i><br>
<i>&gt;       cells' potential for regeneration, contradicting previous</i><br>
<i>&gt;       scientific assumptions. "While it is true that brain cells don't</i><br>
<i>&gt;       regenerate in situ, we have found that a very small number of</i><br>
<i>&gt;       brain cells, harvested and placed into a special environment,</i><br>
<i>&gt;       can be stimulated to regenerate, and that regeneration</i><br>
<i>&gt;       continues when the cells are re-introduced into the brain," says</i><br>
<i>&gt;       neurosurgeon Michel Levesque, M.D., Director of the</i><br>
<i>&gt;       Neurofunctional Surgery Center at Cedars-Sinai Medical Center. </i><br>
<i>&gt; </i><br>
<i>&gt;       Dr. Levesque's partner in the work is Toomas Neuman, Ph.D.,</i><br>
<i>&gt;       Director of Neurobiology at Cedars-Sinai Medical Center. The</i><br>
<i>&gt;       two are working to culture a number of carefully targeted brain</i><br>
<i>&gt;       cells from a patient, stimulating the cell's growth and</i><br>
<i>&gt;       regeneration in a regulated environment. They will then</i><br>
<i>&gt;       re-introduce the cells into the patient, where the goal is for</i><br>
<i>&gt;       growth to continue, effecting healing and repairing damaged</i><br>
<i>&gt;       brain tissue. </i><br>
<i>&gt; </i><br>
<i>&gt;       The current plan involves selective cell harvesting and</i><br>
<i>&gt;       implantation to treat neurodegenerative diseases such as</i><br>
<i>&gt;       Parkinson's Disease. An infinitely more complex protocol for</i><br>
<i>&gt;       treating stroke and spinal cord injuries is in development. </i><br>
<i>&gt; </i><br>
<i>&gt;       This protocol will involve identifying, growing and</i><br>
<i>&gt;       re-introducing a complex mixture of cells to restore damaged</i><br>
<i>&gt;       neural circuitry. For example, in treating epilepsy patients who</i><br>
<i>&gt;       require surgery, a small piece of the cortex -- where some of</i><br>
<i>&gt;       the few brain cells capable of regeneration are located - is</i><br>
<i>&gt;       removed. The cells are frozen and stored in a cell bank of</i><br>
<i>&gt;       neurons until it is time to grow them in petri dishes. </i><br>
<i>&gt; </i><br>
<i>&gt;       Dr. Levesque is the lead surgeon and growth stimulation is</i><br>
<i>&gt;       under the direction of Dr. Neuman. The cells are removed and</i><br>
<i>&gt;       placed in a special environment to stimulate growth and</i><br>
<i>&gt;       division. "The cells don't spontaneously regenerate in the body</i><br>
<i>&gt;       -- that's why certain types of brain injuries and illnesses are</i><br>
<i>&gt;       currently incurable or irreparable," says Dr. Neuman. "Our</i><br>
<i>&gt;       eventual goal is to be able to stimulate the cells without</i><br>
<i>&gt;       removing them first." </i><br>
<i>&gt; </i><br>
<i>&gt;       A variety of molecular biology tools is used to identify and</i><br>
<i>&gt;       stimulate the cells. The growing cells, which require a sterile,</i><br>
<i>&gt;       biologically stable environment, are placed in incubators -- like</i><br>
<i>&gt;       baby incubators. They are then placed in a special bath that</i><br>
<i>&gt;       includes different growth factors. Both the stable environment</i><br>
<i>&gt;       and the bath containing the growth factors are required. </i><br>
<i>&gt; </i><br>
<i>&gt;       Dr. Levesque and Dr. Neuman are collaborating with</i><br>
<i>&gt;       NeuroGeneration, a new biotechnology firm in Los Angeles,</i><br>
<i>&gt;       which is providing the cells. Funding for this research was</i><br>
<i>&gt;       supported in part by the Spinal Cord Society. </i><br>
<pre>
-- 
        sentience@pobox.com         Eliezer S. Yudkowsky
         <a href="http://pobox.com/~sentience/AI_design.temp.html">http://pobox.com/~sentience/AI_design.temp.html</a>
          <a href="http://pobox.com/~sentience/sing_analysis.html">http://pobox.com/~sentience/sing_analysis.html</a>
Disclaimer:  Unless otherwise specified, I'm not telling you
everything I think I know.
</pre>
<!-- body="end" -->
<p>
<ul>
<!-- next="start" -->
<li><a href="3689.html">[ Next ]</a><a href="3687.html">[ Previous ]</a>
<b>In reply to:</b> <a href="0779.html">Brian D Williams</a>
<!-- nextthread="start" -->
</ul>
</body></html>
